📇 Rhumatologue · PARIS · (75) · Salarié

M ARMAND GARIOUD

Pourquoi vous devez consulter ce praticien

4 raisons identifiées

Auteur de référence en rhumatologie
24 articles scientifiques publiés — un praticien à la pointe de la recherche
Référence presse grand public
Cité 1 fois dans les médias — pédagogie reconnue
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 PARIS (75)SalariéRPPS 10001638872

📊 Reconnaissance scientifique : 9/100📝 52 articles publiés🇫🇷 Publications académiques françaises (8)

✨ Génération du profil synthétique IA en cours…

Activité de recherche & publications

Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.

Influence scientifique

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement

Diabetes & metabolism · 2021

📚 32 citations🎯 RCR 2.18Top 24% NIH🔓 Open Access📄 PDF gratuit ↗

Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study

European journal of gastroenterology & hepatology · 2010

📚 30 citations

One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience

European journal of gastroenterology & hepatology · 2017

📚 27 citations🎯 RCR 1.36

Lire l'abstract Crossref ↓

Background Several studies have suggested the efficacy of baclofen in reducing alcohol consumption, leading to a temporary recommendation for use in France. Aim Our aim was to report our experience in using baclofen in alcohol-dependant patients with or without liver cirrhosis. Patients and methods Consecutive patients from two liver and alcohol units were recruited over a 3-year period and received increasing doses of baclofen associated with social, psychological, and medical care. Results One hundred patients were treated, of whom 65 were cirrhotic. After 1 year, 86 patients were still being followed up. At a mean dosage of 40 mg/day (extremes: 30–210), the median daily alcohol consumption reduced from 80 to 0 g/day (P<0.001). Twenty patients drank a small amount of alcohol of up to 30 g/day and 44 patients were completely abstinent. These declarative results were associated with a significant improvement in alcohol-related biological markers in this ‘low-consumption’ group of 64 patients: the median γ-glutamyl transferase decreased from 3.9 to 2.0 UNL (P<0.001), the mean aspartate transaminase decreased from 2.6 to 1.2 UNL (P<0.001), and the mean corpuscular volume decreased from 101 to 93 µm3 (P<0.001). In cirrhotic patients, bilirubinemia decreased significantly from 22 to 11 µmol/l (P=0.026), prothrombin time increased from 68 to 77% (P<0.001), and albuminemia increased from 34.1 to 37.4 g/l (P<0.001). Twenty patients reported grades 1–2 adverse events. No liver or renal function deterioration occurred in cirrhotic patients. Conclusion In our cohort, baclofen associated with a global care was very well tolerated even in cirrhotic patients. The marked reduction in alcohol consumption in 64 patients translated into a significant improvement in biological markers and in liver function tests. Baclofen could be very useful, especially in cases of severe alcoholic liver disease.

Cookies & analyse de trafic

M ARMAND GARIOUD

Pourquoi vous devez consulter ce praticien

Activité de recherche & publications

Publications académiques en France

Lieux de consultation(2)

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Articles de presse (1)

Top publications · les plus citées

Publications scientifiques (24) — classées par pathologie

Transversal20

Épidémiologie & registres3

Pharmacovigilance1

Revue / méta-analyse1

Revue générale1

Partager cette fiche